Palatin Tech investors were really happy about fantastic price gains. Despite the pressure the stock had to suffer from the last few weeks, analysts are still very positive about the stock. The analysts from H.C. Wainwright & Co. still recommend the stock. The experts note that the risks of the core product Bremelanotie, have been decreased drastically.
The current stock price did not reflect the expected catalysators yet. The buy recommendation remains and the price goal is set at solid 5 USD. Currently, the share is noted at 1.34 USD.
Ein Beitrag von Gideon Tanner